[First IVF News Update] NewGenIvf Group Successfully Completes SPAC Merger and Lists on U.S. Nasdaq

On April 4, 2024, Asian fertility services provider NewGenIvf Group Limited (First IVF Group, or NewGenIvf Group) successfully completed a merger with SPAC (Special Purpose Acquisition Company) A SPAC I Acquisition Corp. (ASCA) and officially began trading on the U.S. Nasdaq under the ticker symbol 'NIVF'.

On April 4, 2024, Asian fertility services provider NewGenIvf Group Limited (First IVF Group, or NewGenIvf Group) successfully completed a merger with SPAC (Special Purpose Acquisition Company) A SPAC I Acquisition Corp. (ASCA) and officially began trading on the U.S. Nasdaq under the ticker symbol 'NIVF'.

NewGenIvf Group merger announcement:

https://www.sec.gov/Archives/edgar/data/1981662/000121390024030082/ea0203267-6k_newgenivf.htm

NewGenIvf Group is an integrated fertility services provider in Asia, primarily assisting couples and individuals in accessing fertility treatments. NewGen’s mission is to help couples and individuals build families—regardless of their fertility challenges—by expanding access to infertility care and delivering comprehensive fertility services to its clients. The NewGen Group and its management team bring over a decade of experience in the fertility industry. NewGen operates clinics in Thailand, Cambodia, and Kyrgyzstan, offering full-service fertility care to patients within each respective jurisdiction.

As of market close on the first trading day (April 4), NewGenIvf (NIVF) closed at $1.50 per share, with a current market capitalization of $5.595 million.

As of market close on the first trading day (April 4), NewGenIvf (NIVF) closed at $1.50 per share, with a current market capitalization of $5.595 million.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.